Castration resistant

Castration-Resistant Prostate Cancer: What You Need to Know

Prostate cancer is one of the most common forms of cancer in men. There are some cases where the cancer is resistant to hormone therapy, which is a form of treatment that disrupts the body's production of male hormones, like testosterone, that can fuel the growth of cancer cells. In these cases, castration-resistant prostate cancer (CRPC) is diagnosed, and it requires different treatment options.

Here is what you need to know about CRPC:

• CRPC is a form of advanced prostate cancer that is resistant to traditional hormone therapy. It usually progresses more quickly and is more difficult to manage than other types of prostate cancer.
• It is not curable, but it can be managed with treatments like chemotherapy, immunotherapy, and targeted therapy.
• CRPC is associated with a number of symptoms, including bone pain, bone fractures, fatigue, weight loss, and anemia.
• Early diagnosis and treatment can help to slow the progression of the disease and improve the patient's quality of life.
• Side effects of CRPC treatment vary depending on the type of treatment being used.
• Clinical trials are currently underway to identify new treatments for CRPC.

If you have been diagnosed with CRPC, talk to your healthcare provider about treatment options that are available to you. It is important to understand the benefits and risks of each treatment and work with your provider to develop a treatment plan that is best for you.